P

Inventor

TAVERAS ARTHUR G

US65 patents
⚠️ This page may combine multiple inventors who share the name “TAVERAS ARTHUR G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

38 patents
US5874442AFeb 23, 1999

Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease

SCHERING CORP129 citations99
US6372747B1Apr 16, 2002

Farnesyl protein transferase inhibitors

SCHERING CORP93 citations97
US6362188B1Mar 26, 2002

Farnesyl protein transferase inhibitors

SCHERING CORP85 citations97
US6432959B1Aug 13, 2002

Inhibitors of farnesyl-protein transferase

SCHERING CORP75 citations96
US6387905B2May 14, 2002

Compounds useful for inhibition of farnesyl protein transferase

SCHERING CORP59 citations96
US6228856B1May 8, 2001

Compounds useful for inhibition of farnesyl protein transferase

SCHERING CORP60 citations96
US5721236AFeb 24, 1998

Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP72 citations96
US5719148AFeb 17, 1998

Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

SCHERING CORP92 citations96
US5696121ADec 9, 1997

Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP50 citations96
US6576639B1Jun 10, 2003

Compounds for the inhibition of farnesyl protein transferase

SCHERING CORP23 citations93
US6214828B1Apr 10, 2001

Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease

SCHERING CORP22 citations93
US6124295ASep 26, 2000

Compounds useful for inhibition of farnesyl protein transferase

SCHERING CORP47 citations93
US6071907AJun 6, 2000

Tricyclic compounds useful as FPT inhibitors

SCHERING CORP21 citations93
US6051582AApr 18, 2000

Compounds useful for inhibition of farnesyl protein transferase

SCHERING CORP52 citations93
US6040305AMar 21, 2000

Compounds useful for inhibition of farnesyl protein transferase

SCHERING CORP60 citations93
US5958940ASep 28, 1999

Tricyclic compounds useful as inhibitors of farnesyl-protein transferase

SCHERING CORP33 citations93
US5877177AMar 2, 1999

Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP31 citations93
US6878709B2Apr 12, 2005

3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists

SCHERING CORP20 citations92
US6365588B1Apr 2, 2002

Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP22 citations92
US6242458B1Jun 5, 2001

Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP25 citations92
US6075025AJun 13, 2000

Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP34 citations92
US5861395AJan 19, 1999

Compounds useful for inhibition of farnesyl proteins transferase

SCHERING CORP22 citations92
US5807853ASep 15, 1998

Tricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseases

SCHERING CORP18 citations92
US5728703AMar 17, 1998

Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP34 citations92
US7964646B2Jun 21, 2011

3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

SCHERING CORP10 citations82
US7947720B2May 24, 2011

3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

SCHERING CORP10 citations82
US6492381B1Dec 10, 2002

Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP7 citations74
US6426352B1Jul 30, 2002

Sulfonamide inhibitors of farnesyl-protein transferase

SCHERING CORP10 citations74
US6143758ANov 7, 2000

Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP6 citations74
US5985879ANov 16, 1999

Compounds useful for inhibition of farnesyl protein transferase

SCHERING CORP9 citations74
US5965570AOct 12, 1999

Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase

SCHERING CORP10 citations74
US5958890ASep 28, 1999

Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP10 citations74
US5945429AAug 31, 1999

Compounds useful for inhibition of farnesyl protein transferase

SCHERING CORP8 citations74
US6300338B1Oct 9, 2001

Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

SCHERING CORP1 citations63
US7338968B2Mar 4, 2008

Thiadiazoles AS CXC- and CC- chemokine receptor ligands

SCHERING CORP4 citations62
US7326729B2Feb 5, 2008

CXCR1 and CXCR2 chemokine antagonists

SCHERING CORP6 citations62
US6740661B2May 25, 2004

Farnesyl protein transferase inhibitors

SCHERING CORP2 citations62
US5977128ANov 2, 1999

Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

SCHERING CORP2 citations62

BIOGEN MA INC

6 patents

PHARMACOPEIA DRUG DISCOVERY

2 patents

BIOGEN IDEC INC

2 patents

THOMAS JERMAINE

1 patent

SCHERING CORPORATIONM

1 patent

Showing the top 50 of 65 patents by PatentIndex Score.